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patients. Two of these five had con-
current S. haematobium, compared to
no cases in nonosteomyelitis patients;
a Fisher exact test showed this differ-
ence to be significant (p < 0.02).
These limited and preliminary data
are consistent with the relationship
between leprosy (caused by a
mycobacterium related to the one
causing Buruli ulcer, M. leprae) and
concurrent helminth infections. The
severity of leprosy has recently been
linked to intestinal helminth infection,
whereas the presence or absence of
leprosy has not (7). The cytokine envi-
ronment created by helminth infection
may facilitate disease progression to a
more severe form, or severe mycobac-
terial disease and helminth infection
may have a common risk factor.
We were unable to furnish evi-
dence of a link between the presence
or absence of S. haematobium infec-
tion and Buruli ulcer, but concurrent
infections could influence Buruli
ulcer clinical manifestation and dis-
ease severity.
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1998 Dengue
Hemorrhagic Fever
Epidemic in Taiwan 
To the Editor: The rapid spread-
ing of dengue viruses has led to
increasing incidence rates of dengue
fever (DF), dengue hemorrhagic fever
(DHF), and dengue shock syndrome
(DSS) worldwide in the past 20 years.
The global pandemic of DF and DHF
in 1998 was associated with the
largest DF epidemics many tropical or
subtropical countries had ever experi-
enced (1,2). Here we report the unique
epidemiologic characteristics of DF
and DHF caused by dengue virus type
3 (DEN-3) in Taiwan, where dengue
is not endemic. 
The recent epidemics of dengue in
Taiwan started when dengue virus
type 2 (DEN-2) was first introduced
into the southern off-islet of Hsiao-
Liu-Chiu in 1981 after an absence of
38 years since World War II. Tainan
City in southern Taiwan had not had a
dengue epidemic since l942–1943
until three dengue outbreaks occurred
there in the last decade. The first out-
break of DEN-1 in 1994 and the sec-
ond of DEN-2 in 1997 involved few
confirmed cases. The third epidemic
of dengue, which was attributed to
DEN-3, began in October 1998 and
continued into January 1999. 
From August 1, 1998, to January
31, 1999, physicians in all the hospi-
tals and clinics in Tainan City were
required to report any suspected
dengue cases who met the criteria of
fever (>38oC) and two or more of the
following symptoms and signs:
headache, retroorbital pain, myalgia,
arthralgia, rash, and hemorrhagic
manifestations. Patients who met the
criteria were invited to participate in
the study; informed consent was
given by the patients, and plasma or
serum samples were collected for lab-
oratory confirmation. When a physi-
cian reported a suspected dengue
case, a minimum of 100 blood sam-
ples would be collected from the
patient’s neighbors by the Tainan City
Health Bureau staff. The blood speci-
mens were transported to the labora-
tory at the National Institute of
Preventive Medicine for confirma-
tion. A confirmed dengue case was
required to be positive by either
reverse transcription–polymerase
reaction (3), or demonstrate serocon-
version by dengue-specific
immunoglobulin (Ig) M and seroneg-
ativity for Japanese encephalitis virus
(JEV)-specific IgM by IgM-enzyme-
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linked immunosorbent assay (IgM-
ELISA) (4). Dengue viruses were iso-
lated in C6/36 cell cultures and identi-
fied to serotype with monoclonal anti-
bodies (5). The clinical diagnosis of
DHF was based on the World Health
Organization’s (WHO) criteria that
were revised in 1997. Those con-
firmed dengue cases were classified
as primary, secondary, or indetermi-
nate infections, depending on the ratio
of dengue-specific IgM/IgG as meas-
ured by the capture IgM and IgG
ELISA (6). 
Of 225 case-patients with suspect-
ed dengue, 142 patients, of which 74
(52.5%) were female and 68 (48.2%)
were male (62.7%), had their cases
confirmed by laboratory diagnosis
during the study period. Their ages
ranged from 7 to 79 years (mean: 39
years). Of the 23 DHF case-patients
meeting the WHO’s case definition,
17 were male. The ages of the DHF
case-patients ranged from 13 to 73
years, with a mean age of 42 years. 
The epidemic began in October
and peaked in November. In the
Central District, where the earliest
and majority of DHF cases occurred
(52.2%), the DHF/DF ratio increased
with time, from 11% during the first
interval, to 20% and 30% during the
second and third intervals, respective-
ly. Although this increase was not sta-
tistically significant by Fisher’s exact
test because of the small sample size,
similar results were reported in
Cuba’s DHF epidemic in both 1981
and 1997 (7). Many RNA viruses,
such as influenza, increase in viru-
lence through transmission; possible
virulence mechanisms of dengue
viruses are now under investigation.
In other words, the duration of epi-
demic has to be as short as possible to
avoid the emergence of DHF cases in
that region.
In our study, 88 dengue cases
(62%) were classified as primary
infections, 32 (22.5%) as secondary
infections, and 22 (15.5%) as undeter-
mined because of the lack of paired
acute- and convalescent-phase sam-
ples. DHF cases showed no signifi-
cant association with secondary infec-
tions (odds ratio = 1.92 [95% CI 0.64
to 5.76], p = 0.19). Because the last
documented transmission of dengue
viruses in Taiwan occurred during the
island-wide dengue epidemic in
1942–43, both DF and DHF cases
were stratified into two birth cohort
groups. Of DF case-patients born after
1943, 94% (83/88) had primary infec-
tion, and 11 (92%) of 12 DHF case-
patients had primary infection. By
contrast, 84% (27/32) of all the
dengue case-patients born before and
during 1943 had secondary infection,
and 7 (78%) of 9 DHF case-patients
had secondary infections. After the
cohorts were stratified by age, DHF
cases were not associated with sec-
ondary infection (Mantel-Haenszel)
weighted odds ratio: 0.84 [95% CI:
0.11 to 5.62]) (p = 0.6). Therefore, age
was not a confounding factor or effect
modifier for DHF case-patients in
Tainan’s 1998 epidemic. DHF cases
were mostly associated with primary
infection in Tainan, where no large-
scale epidemic of dengue had been
reported from 1944 to 1997. 
Our observation of DHF in adult
case-patients was different from that
in dengue hyperendemic Asian coun-
tries where 80% of DHF case-patients
are children (8). Dengue virus type 3
was the only serotype isolated during
the epidemic in Tainan in 1998.
However, this situation was similar to
that in Tonga in 1974, where a dengue
virus was also newly introduced (9),
and to recent epidemics in south and
central America (10). More adults
may have been affected because fewer
dengue epidemics, and therefore
fewer exposures to dengue viruses
during childhood, had occurred; sub-
sequently, the immune status in adults
had changed. Presumably, previous
observations of severe dengue in chil-
dren in Southeast Asia were the result
of immunity to infection in the older
population, rather than a particular
susceptibility to DHF among children.
Our results were not influenced by the
age structure of DF and DHF case-
patients in cases of indeterminate
infection or in cases of sub-clinical
infection in children (0.4%, unpub.
data). The dengue virus with epidem-
ic potential replicated to higher
viremia titer and was associated with
disease severity without consideration
of immune status (11). The investiga-
tion on molecular evolution of DEN-3
virus during the 1998 epidemic in
Taiwan, currently in progress, will
elucidate the possible role of virus
variation in the pathogenesis of DHF.
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Rift Valley Fever
Encephalitis
To the Editor: Rift Valley fever
(RVF) is an undifferentiated febrile
illness caused by Rift Valley fever
virus (RVFV). Several human out-
breaks occurred in Africa, resulting in
tens of thousands of infections (1,2).
During fall 2000, an outbreak of RVF
in the Arabian Peninsula (the first
recorded outside of Africa) resulted in
many human and animal fatalities
(3,4). Severe and frequently fatal
encephalitis thought to be directly
related to viral invasion of the central
nervous system develops in <1% of
patients (5). Encephalitis complicat-
ing RVF is poorly described in the lit-
erature, which offers no detailed
description of the clinical findings,
results of cerebrospinal fluid (CSF)
studies, or imaging. We describe a
case of RVF encephalitis associated
with retinitis, including CSF findings,
viral culture results, and neuroradiolo-
gy findings
An 18-year-old woman from Jazan
(southwest of Saudi Arabia) had a 3-
day history of confusion, fever, and
blurred vision at the time an RVF out-
break was peaking in Jazan.
Philadelphia-chromosome–positive
chronic myeloid leukemia (CML) had
been diagnosed in her several months
before (leukocyte count 108 x 109/L).
She responded well to hydroxyurea,
and she had been in stable-phase
CML for a few months. At the time of
her visit, her temperature was 39.2°C,
blood pressure 110/70 mm Hg, pulse
120 beats/min, respiratory rate
22/min. She had no lymphadenopa-
thy, pallor, or jaundice. Results of her
head, neck, and throat examinations
were normal. Her chest was clear, and
her abdomen was soft and nontender.
Her spleen was 3 cm below the left
costal margin. She was conscious and
oriented. No meningeal signs could be
elicited. Pupils were equally reactive
to light with normal extraocular
movements. Extremities had normal
tone, power, sensation, and reflexes.
Plantar reflex was flexor bilaterally.
She had ataxic gait and bilateral reti-
nal hemorrhages. She was unable to
count fingers. Hemoglobin was 100
g/L, leukocyte count 5.1 x 109/L, and
platelets 373 x 109/L. Renal and liver
function tests were normal. Contrast-
enhanced computed tomography (CT)
scan of the brain was normal. Urine
analysis and malaria smear were neg-
ative. CSF was clear. CSF glucose
was 3.9 mmol/L (serum 5.8), protein
455 mg/L. CSF leukocyte count was
323 x 106/L, 58% lymphocytes, and
38% polynuclearleukocytes. Tests for
hepatitis B surface antigen, antibodies
to hepatitis C virus, HIV, cytomega-
lovirus antigenemia, rheumatoid fac-
tor, and antinuclear antibodies were
negative. Cultures from blood, CSF,
and urine were negative for bacteria.
CSF viral culture was negative.
Polymerase chain reaction for herpes
simplex virus and enterovirus from
CSF was negative. Tests for serum
anti-RVF virus immunoglobulin M
were positive. No other tests for
RVFV were performed. Bone marrow
on admission day was consistent with
CML in remission. Prednisone was
started on admission for 7 days.
On hospital day 5, the patient was
noted to be agitated, confused, and
unresponsive to commands. She was
transferred to the intensive care unit
after her level of consciousness
decreased; she was moving all four
limbs but did not respond to verbal
commands or painful stimuli. Pupils
were 5 mm equal bilaterally with a
sluggish reaction to light. Corneal
reflexes were reactive bilaterally. Gag
reflex was present, and tone was
increased in all four limbs with brisk
reflexes and extensor planter respons-
es. The next day, her condition deteri-
orated, and she became unresponsive
to painful stimuli. Repeated CT scan
of the brain showed no pathologic
changes. Electroencephalogram
showed generalized continuous rhyth-
mic sharp and spike wave activity
consistent with nonconvulsive status
epilepticus. Magnetic resonance
imaging (MRI) of the brain showed
bilateral frontoparietal high signal
intensity on T2-weighted images and
evidence of subtle right posterior thal-
amic hyperintensity with no corre-
sponding abnormalities in T1-weight-
ed images. The axial diffusion MRI
images were more elaborative, show-
ing multiple bilateral asymmetrical
cortical hyperintense areas consistent
with an ischemic or inflammatory
process. Phenytoin was started. The
next day, the patient was able to open
her eyes and responded to painful
stimuli, corneal reflexes were present
554 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 3, March 2004